Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Report Date
Robert R. TuftsDirector314,9080.36%2010-01-04
Anthony Dailley,D.D.S.N/A285,2590.33%2014-03-17
Mark M. SieczkarekDirector196,4660.23%2015-03-03
Dr. Behzad Khosrovi,PhDVP Research and Development136,0000.16%2011-05-27
Thomas J. PaulsonCFO68,210less than 0.1%2014-12-12
Mr. Russell A. HoonN/A34,217less than 0.1%2015-04-14
Dr. T. Alexander McPherson,M.D.,PhDDirector28,558less than 0.1%2009-01-14
Mr. David W. StromanSVP, Ophthalmic Product Devt.23,000less than 0.1%2014-12-12
Dr. Harry F. Hixson, JrN/A12,871less than 0.1%2009-04-24
Charles J. CashionDirector226less than 0.1%2007-11-05

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Najafi RaminCEO, 10% Owner
(Click for the stocks that their CEOs have bought)
12,000 (Individual Retirement Account)
Pioneer Pharma (Singapore) Pte10% Owner2015-03-03Buy2,590,0009,595,656$0.61554-759,595,656 (Direct)
SIECZKAREK MARK MDirector2015-03-03Buy166,666196,466$0.6100-75196,466 (Direct)
Najafi RaminChairman2015-03-03Buy166,6663,391,666$0.6100-75
3,391,666 (Ownership through the Najafi Family Trust)
Najafi RaminChairman2014-12-12Buy50,0000$0.6532.5-76.92Link
PAULSON THOMAS JCFO2014-12-12Buy10,00068,210$0.686.8-77.9468,210 (Direct)
Stroman David W.SVP, Ophthalmic Product Devt.2014-12-12Buy10,00023,000$0.666.6-77.2723,000 (Direct)
Najafi RaminChairman2014-12-11Buy20,0003,175,000$0.612-753,175,000 (Direct)
PAULSON THOMAS JCFO2014-12-09Buy10,00058,210$0.676.7-77.6158,210 (Direct)
Najafi RaminChairman2014-12-05Buy25,0003,155,000$0.6516.3-76.923,155,000 (Direct)
Wicks Tony D.S.Director2014-12-02Sell20,0000$0.714-78.57Link
Najafi RaminChairman2014-12-02Buy18,0003,130,000$0.7112.8-78.873,130,000 (Direct)
Wicks Tony D.S.Director2014-12-01Sell10,000213,680$0.696.9-78.26213,680 (Direct)
SIECZKAREK MARK MDirector2014-06-04Buy4,80029,800$0.894.3-83.1529,800 (Direct)
SIECZKAREK MARK MDirector2014-05-19Buy25,00025,000$0.8822-82.9525,000 (Direct)
China Pioneer Pharma Holdings 10% Owner2014-05-13Buy65,0657,613,812$0.9964.4-84.85608,156 (Direct)
7,005,656 (By Pioneer Pharma (Singapore) Pte Ltd)
China Pioneer Pharma Holdings 10% Owner2014-05-12Buy116,1077,548,747$0.99114.9-84.85543,091 (Direct)
7,005,656 (By Pioneer Pharma (Singapore) Pte Ltd)
China Pioneer Pharma Holdings 10% Owner2014-05-09Buy318,8287,432,640$0.99315.6-84.85426,984 (Direct)
7,005,656 (By Pioneer Pharma (Singapore) Pte Ltd)
Pioneer Pharma (Singapore) Pte10% Owner2013-12-02Buy5,000,0007,005,656$1.145700-86.847,005,656 (Direct)
Pioneer Pharma (Hong Kong) Co 10% Owner2013-12-02Buy5,000,0007,005,656$1.145700-86.84
7,005,656 (By Pioneer Pharma (Singapore) Pte. Ltd.)

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column) and "Shares Owned Following This (Direct & Indirect)" transactions (sixth column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership